Max Planck Institute for Infection Biology

Last updated

The Max Planck Institute for Infection Biology (MPIIB) is a non-university research institute of the Max Planck Society located in the heart of Berlin in Berlin-Mitte. It was founded in 1993. [1] Arturo Zychlinsky is currently the Managing Director. [2] The MPIIB is divided into nine research groups, two partner groups and two Emeritus Groups of the founding director Stefan H. E. Kaufmann and the director emeritus Thomas F. Meyer. The department "Regulation in Infection Biology" headed by 2020 Nobel laureate Emmanuelle Charpentier was hived off as an independent research center in May 2018. [3] The Max Planck Unit for the Science of Pathogens is now administratively independent of the Max Planck Institute for Infection Biology. [4] In October 2019, Igor Iatsenko and Matthieu Domenech de Cellès established their research groups at the institute, Mark Cronan started his position as research group leader in March 2020. Silvia Portugal joined the institute in June 2020 as Lise Meitner Group Leader. [5] Two more research groups where added in 2020, Felix M. Key joined in September and Olivia Majer in October, completing the reorganization of the Max Planck Institute for Infection Biology. Simone Reber joined as Max Planck Fellow in 2023 and now heads the research group Quantitative Biology.

Contents

MPI for Infection Biology on Campus Charite Mitte, Berlin MPI fur Infektionsbiologie, Berlin (2009).jpg
MPI for Infection Biology on Campus Charité Mitte, Berlin

Research Groups

Graduate Program

The institute also has an International Max Planck Research School for Infectious Diseases and Immunology in Berlin. [17] The IMPRS-IDI is an English language doctoral program with participating faculty from the Free University of Berlin, Humboldt University of Berlin, the Robert Koch Institute, the German Rheumatism Research Center, and the Leibniz Institute for Zoo and Wildlife Research. The IMPRS-IDI, together with five other graduate schools, forms the "ZIBI Graduate School Berlin". IMPRS-IDI's mission is "better understanding of host-pathogen interactions at all levels". Arturo Zychlinsky is the IMPRS-IDI's spokesperson.

References

  1. "History". www.mpiib-berlin.mpg.de. Retrieved 27 February 2019.
  2. "Prof. Arturo Zychlinsky, PhD". www.mpiib-berlin.mpg.de. Retrieved 27 February 2019.
  3. "Emmanuelle Charpentier". www.nobelprize.org. Retrieved 7 October 2020.
  4. "Emmanuelle Charpentier, CRISPR-Cas9, Max Planck Institute for Infection Biology". Max Planck Unit for the Science of Pathogens. Retrieved 27 February 2019.
  5. "'The best of both worlds'". www.mpiib-berlin.mpg.de. Retrieved 20 April 2021.
  6. "In vivo cell biology of infection". www.mpiib-berlin.mpg.de. Retrieved 8 June 2020.
  7. "Infectious Disease Epidemiology". www.mpiib-berlin.mpg.de. Retrieved 8 June 2020.
  8. "Genetics of Host-Microbe Interactions". www.mpiib-berlin.mpg.de. Retrieved 8 June 2020.
  9. "key_lab". www.mpiib-berlin.mpg.de. Retrieved 20 April 2021.
  10. "Vector Biology". www.mpiib-berlin.mpg.de. Retrieved 8 June 2020.
  11. "Innate Immune Regulation". www.mpiib-berlin.mpg.de. Retrieved 20 April 2021.
  12. "Malaria parasite biology". www.mpiib-berlin.mpg.de. Retrieved 20 April 2021.
  13. ""Suddenly, infectious disease researchers got interested in our work"". www.mpiib-berlin.mpg.de. Retrieved 10 August 2023.
  14. "Visualisation of Immune Signalling". www.mpiib-berlin.mpg.de. Retrieved 8 June 2020.
  15. "Cellular Microbiology". www.mpiib-berlin.mpg.de. Retrieved 8 June 2020.
  16. "Molecular Biology". www.mpiib-berlin.mpg.de. Retrieved 8 June 2020.
  17. "ZIBI and ZIBI Graduate School". www.zibi-berlin.de. 1 February 2017. Retrieved 27 February 2019.

52°31′30″N13°22′31″E / 52.52500°N 13.37528°E / 52.52500; 13.37528